Clinical ResearchInterventional CardiologyLong-Term Outcomes After Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability From the Canadian Multicenter Experience
Key Words
Abbreviations and Acronyms
Cited by (0)
This study was supported in part by a grant of the Foundation of the Quebec Heart and Lung Institute, a grant of the Canadian Institutes of Health Research (MOP 57745), and a grant from Edwards Lifesciences Inc. Drs. Rodés-Cabau, Webb, Cheung, Ye, Dumont, Velianou, and Thompson are consultants for Edwards Lifesciences Inc. Dr. Rodés-Cabau, Webb, and Cheung are consultants for St. Jude Medical. Dr. Natarajan is a proctor for Edwards Lifesciences Inc. Dr. DeVarennes is a proctor for Medtronic. Dr. Pibarot holds the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada. Dr. Horlick is a proctor and consultant for Edward Lifesciences Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. This study was selected for presentation as “Featured Clinical Study” at the 2012 American College of Cardiology Scientific Sessions, Chicago, Illinois.